Algo version: 0.98b
Noxopharm Limited is listed at the PNK Exchange
Noxopharm Limited [NOXOF]
PNK Sector: Healthcare Industry:Biotechnology

Is Noxopharm Limited stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Noxopharm Limited 10 years ago, but if you had invested on Wednesday 29th of January 2020 when the price was $0.190, you would have made a loss of $-0.145 per share or -76.32%

We do not have enough data to give you this answer.

Noxopharm Limited has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Noxopharm Limited to be medium [0.7 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.